Pharmacy Smoking Cessation Service: Complete Delivery Guide

Smoking remains the leading cause of preventable death. Patients want to quit but struggle alone. Pharmacy smoking cessation services provide the support that makes the difference.

Community pharmacies are ideally placed for smoking cessation. Accessible without appointment. Regular contact through prescription collection. Trusted healthcare relationship already established.

Service Models

Community pharmacies have become the primary providers of smoking cessation support in the UK because they combine clinical expertise with unmatched accessibility. According to NHS Digital data, there are approximately 11,500 community pharmacies in England alone, significantly outnumbering GP practices, and most offer walk-in access without appointments during extended hours including evenings and weekends. The evidence base for pharmacy-led smoking cessation is robust: NICE guidance PH10 and NG92 specifically recommend community pharmacy as a setting for stop-smoking services, and research published in the British Medical Journal has shown that pharmacy interventions achieve comparable quit rates to GP-based services. For pharmacy owners, smoking cessation represents both a commissioned NHS service generating £100–200 per successful quit and a gateway to private consultations — patients who engage with cessation support often go on to access other pharmacy health services. Digital platforms enable pharmacies to schedule structured follow-up appointments, track carbon monoxide readings over time, manage NRT prescriptions, and maintain the documentation required for service claims.

NHS Commissioned Services

Many areas commission pharmacy smoking cessation. Structured programmes. Defined consultation schedule. NRT supply included. Outcome-based payments.

Private Services

Where NHS services are unavailable, private smoking cessation offers opportunity. Patients pay for consultations and products. Set competitive pricing. Professional service delivery.

Brief Interventions

Every interaction is opportunity. Ask about smoking status. Offer support. Signpost to services. Brief interventions prompt quit attempts.

Consultation Framework

Building an effective pharmacy smoking cessation programme requires a structured approach combining behavioural support with appropriate pharmacotherapy. The programme should follow NICE guidance NG92, which recommends an initial assessment consultation of 20 to 30 minutes followed by weekly follow-up sessions for at least four weeks after the quit date. During the initial consultation, assess nicotine dependence using the Fagerström Test, discuss pharmacotherapy options including nicotine replacement therapy, varenicline, and bupropion, and agree a quit date within two weeks. NRT is available over the counter, but varenicline and bupropion require a prescription — pharmacist independent prescribers can prescribe these directly, while others may need to refer to a GP. Each follow-up session should include carbon monoxide monitoring to validate abstinence, motivational support, and medication review. Digital consultation platforms like RxSure streamline this workflow with structured templates that guide clinicians through each appointment stage, automated follow-up scheduling, and outcome tracking that generates the reports needed for commissioner service claims.

Initial Assessment

Understand smoking history. Cigarettes per day. Previous quit attempts. What worked and what did not. Motivation level. Preferred quit approach.

Product Selection

Match NRT to patient preference and smoking pattern. Patches for steady release. Inhalators for hand-to-mouth habit. Combination therapy for heavy smokers.

Behavioural Support

Products alone are not enough. Identify triggers. Plan coping strategies. Build support network. Address psychological dependence alongside physical.

Ongoing Support

The pharmacological options for smoking cessation in UK pharmacy practice encompass three main categories, each with distinct prescribing considerations. Nicotine replacement therapy, available as patches, gum, lozenges, inhalers, nasal spray, and mouth spray, can be supplied over the counter without a prescription and is the most commonly used first-line treatment. Varenicline, marketed as Champix before its withdrawal and now available as generic varenicline, is a prescription-only medicine that acts as a partial nicotine receptor agonist and has the highest individual quit rates in clinical trials, with approximately 25 per cent of users remaining abstinent at 12 months compared to 15 per cent with NRT alone. Bupropion is an alternative prescription-only option that reduces cravings through its action on dopamine and noradrenaline pathways. Pharmacist independent prescribers registered with the GPhC can prescribe both varenicline and bupropion within their competence, while pharmacists without IP status can supply NRT and refer patients requiring prescription medications. Combination therapy using NRT patches with a fast-acting form is recommended by NICE as it improves quit rates.

Follow-Up Schedule

Regular follow-up improves success rates. Weekly initially. Then fortnightly. Adjust support as needed. Celebrate milestones.

Managing Setbacks

Lapses happen. Do not treat as failure. Understand what happened. Adjust approach. Maintain motivation. Every quit attempt builds toward success.

Carbon Monoxide Monitoring

CO monitoring provides objective measure. Validates quit status. Motivates patients seeing levels drop. Required for some commissioned services.

Help Patients Quit

Smoking cessation saves lives. Pharmacy support significantly improves quit rates. Professional service delivery makes the difference.

RxSure supports smoking cessation services with consultation templates, follow-up scheduling, and outcome tracking. Help more patients quit.

Start your free trial and enhance your stop smoking service.